An experiment may solve a serious limitation facing lab-grown human tissue transplants. » Read More
By: Dan Mangan
Republicans last week canceled a planned vote on an Obamacare replacement plan after it became clear that the bill would fail. » Read More
By: Maggie Fox
Despite ACHA's failure, Trump has signaled that he does not plan to defend Obamacare or its provisions, NBC reports. » Read More
By: Lauren Thomas
Hospital-related stocks started the week in the green following the failure of the GOP's effort to replace Obamacare. » Read More
Biotech stocks endured a rough Monday, and struggles may continue throughout the year for the high-growth sector, one trader said.
Several factors are being overlooked when discussing drug pricing in the U.S., three pharma CEOs say.
Celgene Chairman and CEO Bob Hugin, discusses his outlook for the health care industry, and M&A in the space.
Discussing research and development in the biotech space, and drug pricing responsibly, with Johnson & Johnson CEO Alex Gorsky.
Liquid biopsies that show genetic mutations of DNA in a person's blood will dramatically improve early detection of cancers.
Insight to the regulatory process of pricing drugs, with Ian Read, Pfizer Chairman and CEO.
The JPMorgan Health Care Conference, which kicks off next week, could take on a more muted tone than in previous years.
CNBC's Meg Tirrell reports the latest news in the health care sector including Shire buying Baxalta for $32 billion and the formation of a new company to develop a blood test for cancer.
The Obama administration said recently that more than 11 million have signed up for health insurance. Experts see it differently.
Updated guidelines warn that consuming any amount of alcohol increases the risk to your health.
Mount Sinai Hospital's CEO told CNBC that while Obamacare survived a repeal attempt, it's locked in a tough game of numbers.
Virtual reality is the newest tech toy, but dizziness and other side effects could derail the momentum, says Doug Magyari.
Researchers have found that blocking a receptor in the brain that regulates immune cells could benefit the treatment of Alzheimer's.
An unknown number of Fitbit accounts reportedly have been breached by unidentified people who changed their settings.
A report commissioned by NASA discusses the risks of one of the agency's big goals: more human space travel.
Martin Shrekli is using a brokerage account to secure his $5 million bond to keep him out of jail as he fights fraud charges.
The Obama administration is looking to draw in more uninsured customers as open enrollment nears its Jan. 31 deadline.
Valeant Pharmaceuticals on Wednesday named Howard Schiller interim chief executive officer, effective immediately.
There hasn't been a significant increase in part-time jobs due to the Affordable Care Act.
Lumosity claimed its brain games could improve mental performance and stave off age-related cognitive decline.
Get the best of CNBC in your inbox